Physician profile
Alan Rosen
NPI 1235102930
$2,104.08
in general payments reported to CMS, 2019-2025
14 companies · $89.36 in 2025
The $89.36 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,118 · 2020: $648 · 2023: $249 · 2025: $89.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $811.66 | 2019-2025 | Skyrizi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $274.51 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $166.57 | 2019-2020 | |
| Medtronic, INC. | $149.99 | 2023 | Gi Genius |
| Pfizer INC. | $136.78 | 2019-2020 | |
| Gilead Sciences, INC. | $118.83 | 2019-2020 | |
| Amarin Pharma, INC. | $108.99 | 2019 | |
| Novo Nordisk INC | $95.02 | 2019 | |
| Allergan, INC. | $82.90 | 2019 | |
| Ironwood Pharmaceuticals, INC | $50.08 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $39.28 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $30.94 | 2019 | |
| Alfasigma USA, INC. | $20.17 | 2020 | |
| Braintree Laboratories, INC. | $18.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.